中草药

基于UPLC-Q-TOF-MS/MS的马氏珍珠贝肉治疗再生障碍性贫血的药效物质基础研究

PDF下载

梁钰莹, 黄秋婷, 覃宁宁, 秦柳柳, 覃豪丽, 郝二伟, 杜正彩, 邓家刚, 侯小涛

中草药 | 海洋中药研究 2026,57(14): 5379-5395

收起

中草药 |海洋中药研究 2026 , 57 (14) : 5379 -5395

基于UPLC-Q-TOF-MS/MS的马氏珍珠贝肉治疗再生障碍性贫血的药效物质基础研究

全屏

梁钰莹, 黄秋婷, 覃宁宁, 秦柳柳, 覃豪丽, 郝二伟, 杜正彩, 邓家刚, 侯小涛

作者信息

通讯作者:

邓家刚

作者简介:

梁钰莹: 梁钰莹（1998—），女，硕士研究生，研究方向为海洋中药学。E-mail:1040970474@qq.com

Pharmacological substance basis of Pteria martensii meat in treatment of aplastic anemia based on UPLC-Q-TOF-MS/MS

LIANG Yuying, HUANG Qiuting, QIN Ningning, QIN Liuliu, QIN Haoli, HAO Erwei, DU Zhengcai, DENG Jiagang, HOU Xiaotao

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.14.003

文章导航

摘要

收起

目的探究马氏珍珠贝肉提取物（Pteria martensii meat extract，PMME）对再生障碍性贫血大鼠（aplastic anemia，AA）的治疗作用，并对其入血成分进行表征鉴定。方法采用环磷酰胺和乙酰苯肼联合建立AA大鼠模型，给予药物干预后，考察PMME对AA大鼠外周血血细胞、骨髓有核细胞、骨髓形态变化及血清中肿瘤坏死因子-α（tumor necrosis factor-α，TNF-α）、γ干扰素（interferon-γ，IFN-γ）、促红细胞生成素（erythropoietin，EPO）水平和骨髓悬液中血管内皮细胞生长因子A（vascular endothelial growth factor-A，VEGF-A）、血管内皮细胞黏附分子-1（vascular cell adhesion molecule-1，VCAM-1）水平的影响。采用超高效液相色谱-四级杆-飞行时间串联质谱（UPLC-Q-TOF-MS/MS）技术对PMME进行定性分析，并对比正常大鼠和AA大鼠ig PMME后的入血成分差异。结果与模型组比较，PMME组大鼠外周血中红细胞、白细胞数量和血红蛋白水平明显升高（P＜0.01），血小板数量显著减少（P＜0.05、0.01），血清中TNF-α、IFN-γ、EPO水平显著降低（P＜0.05、0.01），骨髓悬液中VEGF-A、VCAM-1水平显著升高（P＜0.05），骨髓有核细胞数量显著增加（P＜0.05、0.01），且大鼠骨髓破坏程度明显减轻。从PMME中鉴定出氨基酸类、核苷类、有机酸类、维生素类、嘌呤类、固醇类等69个成分，其中主要化学成分为有机酸类、氨基酸类、核苷类。正常大鼠含药血浆中鉴定出缬氨酸、二十碳一烯酸、组氨酸、花生酸4个成分，AA大鼠含药血浆中鉴定出苯丙氨酸、二十碳一烯酸、酪氨酸、癸二酸、亚油酸、棕榈酸、异亮氨酸7个成分。结论 PMME对AA大鼠有明显的治疗作用，能够有效改善AA大鼠的各项指标和骨髓破坏程度。PMME的主要成分为有机酸类、氨基酸类及核苷类，二十碳一烯酸、组氨酸以原型成分或代谢物形式入血，可作为治疗AA大鼠的药效物质基础。

关键词

马氏珍珠贝肉 / UPLC-Q-TOF-MS/MS / 再生障碍性贫血 / 分子对接 / 二十碳一烯酸 / 组氨酸

Abstract

收起

Objective To explore the therapeutic effect of Pteria martensii meat extract (PMME) on aplastic anemia (AA) rats and characterize its components entering the blood. Methods An AA rat model was established by combined administration of cyclophosphamide and acetylphenylhydrazine. After drug intervention, the effects of PMME on peripheral blood cells, bone marrow nucleated cells, bone marrow morphological changes, levels of tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), erythropoietin (EPO) in serum and levels of vascular endothelial growth factor-A (VEGF-A), vascular cell adhesion molecule-1 (VCAM-1) in bone marrow suspension of AA rats were investigated. Ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS) was employed for the qualitative analysis of PMME, and the differences in components entering the blood between normal rats and AA rats after ig PMME were compared. Results Compared with model group, the numbers of red blood cells, white blood cells and hemoglobin level in peripheral blood of rats in PMME group were significantly increased (P < 0.01), the number of platelets was significantly decreased (P < 0.05, 0.01), the levels of TNF-α, IFN-γ and EPO in serum were significantly decreased (P < 0.05, 0.01), the levels of VEGF-A and VCAM-1 in bone marrow suspension were significantly increased (P < 0.05), the number of nucleated cells in bone marrow significantly was increased (P < 0.05, 0.01), and the degree of bone marrow destruction in rats was significantly reduced. A total of 69 components including amino acids, nucleosides, organic acids, vitamins, purines and sterols were identified from PMME, with the main chemical components being organic acids, amino acids, and nucleosides. Four components, namely valine, eicosaenoic acid, histidine, and arachidonic acid, were identified in the drug containing plasma of normal rats, while seven components, namely phenylalanine, eicosaenoic acid, tyrosine, sebacic acid, linoleic acid, palmitic acid, and isoleucine, were identified in the drug containing plasma of AA rats. Conclusion PMME has a significant therapeutic effect on AA rats and can improve various indicators and bone marrow damage in AA rats. The main components of PMME are organic acids, amino acids, and nucleosides, with eicosaenoic acid and histidine entering the bloodstream in the form of prototype components or metabolites, which can serve as the pharmacological substance basis for treating AA rats.

Key words

Pteria martensii (Dunker) meat / UPLC-Q-TOF-MS/MS / aplastic anaemia / molecular docking / eicosenoic acid / histidine

引用本文

梁钰莹, 黄秋婷, 覃宁宁, 秦柳柳, 覃豪丽, 郝二伟, 杜正彩, 邓家刚, 侯小涛. 基于UPLC-Q-TOF-MS/MS的马氏珍珠贝肉治疗再生障碍性贫血的药效物质基础研究. 中草药, 2026 , 57 (14) : 5379 -5395 . DOI: 10.7501/j.issn.0253-2670.2026.14.003

LIANG Yuying, HUANG Qiuting, QIN Ningning, QIN Liuliu, QIN Haoli, HAO Erwei, DU Zhengcai, DENG Jiagang, HOU Xiaotao. Pharmacological substance basis of Pteria martensii meat in treatment of aplastic anemia based on UPLC-Q-TOF-MS/MS[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (14) : 5379 -5395 . DOI: 10.7501/j.issn.0253-2670.2026.14.003

基金

收起

广西科技重大专项 (桂科AA22117003); “尖锋”行动计划 (广西重大专项计划); 广西海洋中药资源及标准调研[桂药监科 (2023)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

毛悦, 靳楠, 王文儒, 等. 麻柔运用顾护脾胃冲和之气法治疗再生障碍性贫血经验[J]. 中国中医基础医学杂志, 2023, 29(10): 1745-1748.
董孟锡, 李秀军. 李秀军教授治疗慢性再生障碍性贫血的经验[J]. 中西医结合心血管病电子杂志, 2020, 8(19): 179-180.
左祥宇, 王爱迪, 刘宝山. 再生障碍性贫血病机分析[J]. 天津中医药大学学报, 2017, 36(4): 248-250.
李碧云, 韩亚辉, 殷楚云, 等. 艾曲泊帕联合免疫抑制治疗对重型再生障碍性贫血的疗效和安全性的Meta分析[J]. 中国药房, 2023, 34(15): 1891-1898.
卢文婕, 张琳, 杨李, 等. 环孢素A治疗儿童非重型再生障碍性贫血的转归效果及预后因素分析[J]. 中国实验血液学杂志, 2021, 29(4): 1257-1261.
王兰华, 李树勇, 吴康. 环孢素联合雄性激素治疗非重型再生障碍性贫血的临床疗效观察[J]. 中国全科医学, 2016, 19(B12): 152-154.
魏元凤, 黄东平. 造血干细胞移植治疗再生障碍性贫血的现状[J]. 中国组织工程研究, 2020, 24(19): 3093-3100.
赵鹏, 杨义武, 马林通, 等. rhG-CSF联合强烈免疫抑制治疗再生障碍性贫血并发感染的效果[J]. 中华医院感染学杂志, 2021, 31(9): 1358-1362.
Ramos-Peñafiel C O, Ferrer-Argote V E, Trejo-Ayala R, et al. Androgens added to immunosuppressive regimen in patients with aplastic anaemia. A retrospective study [J]. Rev Médica Del Hosp Gen De México, 2015, 78(3): 107-111.
郝晶, 孙凤, 王金环, 等. 补肾生血法对慢性再生障碍性贫血患者Th22影响的研究[J]. 时珍国医国药, 2016, 27(10): 2359-2360.
王懋元, 汤欣雨, 刘迪, 等. 益髓解毒方对再生障碍性贫血小鼠骨髓造血功能及VEGF表达的影响[J/OL]. 中国免疫学杂志, (2026-06-18) [2026-06-26]. https://link.cnki.net/urlid/22.1126.R.20260617.1659.002.
王金环, 代月, 张炫娜, 等. 补肾生血法治疗慢性再生障碍性贫血的疗效及对CD11a细胞粘附分子的影响[J]. 时珍国医国药, 2020, 31(6): 1302-1304.
广西中药材标准[S]. 1992: 171.
刁石强, 李来好, 陈培基, 等. 马氏珍珠贝肉风味食品开发研究[J]. 湛江海洋大学学报, 1999(2): 34-39.
刁石强, 李来好, 陈培基. 马氏珍珠贝肉营养成分分析及评价[J]. 浙江海洋学院学报: 自然科学版, 2000, 19(1): 42.
李来好, 刁石强, 陈培基, 等. 南海珍珠贝肉的营养成分分析与评价[J]. 水产学报, 1999(4): 392-397.
刘书成, 李德涛, 高加龙, 等. 近江牡蛎等3种贝类的脂类成分分析[J]. 水产学报, 2009, 33(4): 666-671.
吴红棉, 雷晓凌, 洪鹏志, 等. 珠母贝糖胺聚糖的结构初探及其生理活性[J]. 水产学报, 2001, 25(2): 166-170.
张焱, 杨书婷, 韦小翠, 等. 马氏珍珠贝中核苷类成分的分离富集工艺研究[J]. 食品工业科技, 2020, 41(17): 173-180.
章超桦, 吴红棉, 洪鹏志, 等. 马氏珠母贝肉的营养成分及其游离氨基酸组成[J]. 水产学报, 2000, 24(2): 180-184.
郝记明. 酶法水解马氏珠母贝肉制备血管紧张素转换酶抑制肽的研究[D]. 北京: 中国农业大学, 2005.
张政委. 酶解马氏珠母贝肉制备降血压肽的研究[D]. 南宁: 广西大学, 2008.
陈方, 吴铁, 艾春媚, 等. 马氏珠母贝全脏器提取物糖胺聚糖抗肿瘤作用的实验研究[J]. 中国临床药理学与治疗学, 2002, 7(6): 511-514.
范秀萍, 吴红棉, 雷晓凌, 等. 珠母贝氨基多糖的分离纯化及其抗肿瘤活性的初步研究[J]. 中国海洋药物, 2005, 24(2): 32-36.
胡雪琼, 吴红棉, 范秀萍, 等. 珠母贝糖胺聚糖抗肿瘤作用初步研究[J]. 食品工业科技, 2013, 34(22): 315-319.
凌霄, 陈传, 艾春媚. 马氏珠母贝糖胺聚糖体外抑制HL-60肿瘤细胞作用的初步观察[J]. 中国现代应用药学, 2006, 23(S2): 737-738.
吴燕燕, 宫晓静, 李来好, 等. 风味蛋白酶水解合浦珠母贝肉制备抗菌肽人工神经网络法优化工艺[J]. 食品科学, 2011, 32(20): 63-68.
于文媛. 马氏珠母贝抗菌肽的初步分离及抗菌活性分析[D]. 海口: 海南大学, 2011.
于文媛, 王世锋, 谢珍玉, 等. 合浦珠母贝抗菌肽粗提液制备方法的优化[J]. 热带生物学报, 2011(1): 14-20.
朱家萍. 马氏珠母贝血清抗菌活性蛋白的分离纯化与鉴定[D]. 湛江: 广东海洋大学, 2015.
范秀萍, 吴红棉, 王娅楠, 等. 4种贝类糖胺聚糖体外清除自由基活性的比较[J]. 食品科技, 2008, 33(2): 165-167.
李雨哲, 任娇艳, 赵谋明. 马氏珍珠贝糖蛋白分离纯化及其抗氧化活性的研究[J]. 食品与发酵工业, 2010, 36(10): 30-32.
李雨哲, 任娇艳, 赵谋明. 马氏珍珠贝肉糖蛋白的提取工艺优化及其抗氧化活性的研究[J]. 食品工业科技, 2011, 32(4): 243-245.
卢传亮, 郑上华, 童银洪. 马氏珠母贝多糖提取及其保湿性研究[J]. 现代农业科技, 2013(21): 254-256.
田倩, 吴燕燕, 李来好, 等. 合浦珠母贝肉酶解液中抗氧化肽的分离及活性研究[J]. 食品科学, 2011, 32(S1): 144-148.
吴红棉, 雷晓凌, 洪鹏志, 等. 珠母贝糖胺聚糖的结构初探及其生理活性[J]. 水产学报, 2001, 25(2): 166-170.
章超桦, 刘亚, 杨萍, 等. 马氏珠母贝肉酶解蛋白抗疲劳功能的初步研究[J]. 中国海洋药物, 2006, 25(4): 46-47.
王利霞, 章超桦, 高加龙, 等. 马氏珠母贝肉提取物对小鼠急性酒精性肝损伤的影响[J]. 广东海洋大学学报, 2021, 41(6): 99-107.
山东省中药材标准[S]. 2012: 132
张敬礼. 寿世补元[M]. 北京: 中国医药科技出版社, 2002: 145
邓培颖, 李雪, 韦翊, 等. 补肾生血解毒方及拆方对免疫介导再生障碍性贫血小鼠T淋巴细胞增殖和分化的影响[J]. 中华中医药杂志, 2018, 33(7): 3014-3018.
杜青, 何丹, 黄建华, 等. 四物膏对再生障碍性贫血模型大鼠骨髓造血功能的影响[J]. 中国实验方剂学杂志, 2021, 27(3): 92-98.
张玉, 董文婷, 霍金海, 等. 基于UPLC-Q-TOF-MS技术的广地龙化学成分分析[J]. 中草药, 2017, 48(2): 252-262.
严曾豪, 李雯珊, 梁冰宜, 等. 基于UPLC-Q-TOF-MS/MS技术比较板蓝根和大青叶的化学成分[J]. 中草药, 2024, 55(12): 3956-3965.
杨彦涛, 李卓伦, 周霖, 等. 基于UHPLC-Q-Orbitrap HRMS技术的肾康注射液在大鼠体内代谢产物的鉴定及代谢途径分析[J]. 中草药, 2024, 55(3): 730-745.
严志宏, 葛浩宇, 罗珍, 等. 基于UPLC-Q-TOF-MS/ MS网络药理学的九制黄精与生黄精对脂多糖诱导RAW264.7细胞炎症反应的抑制作用差异研究[J]. 药物评价研究, 2025, 48(12): 3551-3569.
Al Aidaros A, Sharma C, Langhans C D, et al. Targeted metabolomic profiling of total fatty acids in human plasma by liquid chromatography-tandem mass spectrometry [J]. Metabolites, 2020, 10(10): 400.
Han J, Lin K, Sequeira C, et al. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry [J]. Anal Chim Acta, 2015, 854: 86-94.
Xu T R, Hu C X, Xuan Q H, et al. Recent advances in analytical strategies for mass spectrometry-based lipidomics [J]. Anal Chim Acta, 2020, 1137: 156-169.
Wu H L, Yang C Y, Hao R J, et al. Lipidomic insights into the immune response and pearl formation in transplanted pearl oyster Pinctada fucata martensii [J]. Front Immunol, 2022, 13: 1018423.
潘龙祥, 高喜梅, 乔萍, 等. 基于UPLC-Q-TOF-MS/MS技术结合化学模式识别分析温胆汤不同工艺的差异性成分[J]. 中草药, 2025, 56(8): 2811-2828.
张新佳, 王戟森, 梅宇翔, 等. 基于UPLC-Q-TOF-MS/MS与Python算法的伤科接骨片成分自动解析[J]. 分析测试学报, 2026, 45(6): 1234-1244.
刘权, 肖观林, 刘焰嫦, 等. 基于UPLC-Q-TOF-MS/MS结合多元统计方法的不同产地石柑子药材质量评价[J]. 中药材, 2026, 49(3): 678-684.
Rajendran K, Chellappan D R, Ramakrishnan V, et al. Therapeutic efficacy of Punarnavadi mandura against phenylhydrazine-induced hemolytic anemia in rats [J]. J Tradit Complementary Med, 2025, 15(1): 93-104.
Shin J Y, Hu W H, Naramura M, et al. High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias [J]. J Exp Med, 2014, 211(2): 217-231.
Rokkam V R, Killeen R B, Kotagiri R. Secondary Thrombocytosis [M/OL]. Treasure Island (FL): StatPearls Publishing, (2024-08-06) [2026-05-10]. https:// europepmc.org/article/MED/32809645.
Jeon G W. Pathophysiology, classification, and complications of common asymptomatic thrombocytosis in newborn infants [J]. Clin Exp Pediatr, 2022, 65(4): 182-187.
Bleeker J S, Hogan W J. Thrombocytosis: Diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies [J]. Thrombosis, 2011, 2011(1): 536062.
Bhatta G, Meseeha M, Khan M, et al. Response of thrombocytosis after iron replacement therapy in patients with iron deficiency Anemia [J]. Blood, 2024, 144: 5259.
Sharma V, Bagrodia V, Modi N M, et al. Marked reactive thrombocytosis in a female with iron deficiency anaemia [J]. BMJ Case Rep, 2023, 16(11): e256738.
Kaser A, Brandacher G, Steurer W, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: Role in inflammatory thrombocytosis [J]. Blood, 2001, 98(9): 2720-2725.
Chiu Y G, Aljitawi O S. VCAM-1⁺ macrophages usher hematopoietic stem and progenitor cell to vascular niche “hotspots” [J]. Ann Transl Med, 2019, 7(S3): S116.
Li D T, Xue W Z, Li M, et al. VCAM-1⁺ macrophages guide the homing of HSPCs to a vascular niche [J]. Nature, 2018, 564(7734): 119-124.
Melincovici C S, Boşca A B, Şuşman S, et al. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis [J]. Rom J Morphol Embryol, 2018, 59(2): 455-467.
邓梦云, 杨丽娟, 李莉, 等. 补髓生血丸对再生障碍性贫血小鼠造血功能及骨髓VEGF、TPO、VCAM-1水平的影响[J]. 中药新药与临床药理, 2023, 34(1): 42-48.
Tripathy N K, Singh S P, Nityanand S. Enhanced adipogenicity of bone marrow mesenchymal stem cells in aplastic Anemia [J]. Stem Cells Int, 2014, 2014: 276862.
Naveiras O, Nardi V, Wenzel P L, et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment [J]. Nature, 2009, 460(7252): 259-263.
Wang C Z, Li J H, Liu K H, et al. Donkey-hide gelatin-derived carbon dots activate erythropoiesis and eliminate oxidative stress for aplastic anemia treatment [J]. ACS Nano, 2025, 19(2): 2922-2935.
Sales-Campos H, Reis de Souza P, Crema Peghini B, et al. An overview of the modulatory effects of oleic acid in health and disease [J]. Mini Rev Med Chem, 2013, 13(2): 201-210.
Kumar N G, Contaifer D, Madurantakam P, et al. Dietary bioactive fatty acids as modulators of immune function: Implications on human health [J]. Nutrients, 2019, 11(12): 2974.
Kim K H, Kim Y, Seo K W. Efficacy of monounsaturated fatty acids in reducing risk of the cardiovascular diseases, cancer, inflammation, and insulin resistance: A narrative review [J]. Ann Clin Nutr Metab, 2023, 15(1): 2-7.
Schoettler M L, Nathan D G. The pathophysiology of acquired aplastic Anemia: Current concepts revisited [J]. Hematol Oncol Clin North Am, 2018, 32(4): 581-594.
Brosnan M E, Brosnan J T. Histidine metabolism and function [J]. J Nutr, 2020, 150: 2570S-2575S.
Zhang Z Z, Fan M L, Hao X, et al. Integrative drug efficacy assessment of Danggui and European Danggui using NMR-based metabolomics [J]. J Pharm Biomed Anal, 2016, 120: 1-9.
Niknahad H, Mehrabani P S, Arjmand A, et al. Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine [J]. Ceh, 2023, 9(1): 79-92.
Vera-Aviles M, Moreno-Fernandez J, Kose T, et al. Effect of histidine and carnosine on haemoglobin recovery in anaemia induced-kidney damage and iron-loading mouse models [J]. Amino Acids, 2025, 57(1): 26.

2026年第57卷第14期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.14.003

接收时间：2026-02-26
首发时间：2026-09-10

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2026-02-26

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.14.003

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT